Does NIVOLUMAB Cause Decreased appetite? 2,619 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,619 reports of Decreased appetite have been filed in association with NIVOLUMAB (OPDIVO). This represents 3.0% of all adverse event reports for NIVOLUMAB.
2,619
Reports of Decreased appetite with NIVOLUMAB
3.0%
of all NIVOLUMAB reports
452
Deaths
1,429
Hospitalizations
How Dangerous Is Decreased appetite From NIVOLUMAB?
Of the 2,619 reports, 452 (17.3%) resulted in death, 1,429 (54.6%) required hospitalization, and 160 (6.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Dyspnoea (2,527)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which NIVOLUMAB Alternatives Have Lower Decreased appetite Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE